PMID: 6171872Jan 1, 1981Paper

Lupus erythematosus (LE) factors recognize both nucleosomes and viable human leucocytes

Scandinavian Journal of Immunology
O P Rekvig, K Hannestad

Abstract

The morphological LE test was completely inhibited by mixing LE-factor-positive sera with core mononucleosomes, the basic histone-DNA subunit of chromatin. Free DNA and free histones at physiological ionic strength were not inhibitory. The LE-factor-binding antigen was virtually completely regained by mixing DNA and the inner histones H2A, H2B, H3 and H4 in 2 M NaCl, followed by step dialysis to 0.15 M salt. Trypsin-digested core mononucleosomes did not inhibit the LE test, indicating that the antigenic site is located on the N-terminal region of the histones. Twenty-six out of twenty-seven LE-factor-positive sera contained antinuclear antibodies that cross-reacted with plasma membranes of viable leucocytes (referred to as X-ANA). By contrast, weak X-ANA activity was found in only two out of twenty-five LE-factor-negative sera with high ANA titres. Three LE-factor-positive sera were subjected to absorption with viable human leucocytes, which led to the complete disappearance of LE factor activity of all three sera. The data indicate that antibodies with LE factor activity recognize core mononucleosomes and a plasma membrane antigen of viable human leucocytes.

References

Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A Ruiz-CarrilloR Lurz
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A SteinM Bina
Jan 1, 1978·Scandinavian Journal of Immunology·K Hannestad
Jan 1, 1979·Scandinavian Journal of Immunology·O P Rekvig, K Hannestad
Oct 19, 1978·Nature·K Hannestad, B D Stollar
Jan 1, 1976·Scandinavian Journal of Immunology·K Hannestad, A Johannessen
Nov 29, 1977·Biochemistry·K Tatchell, K E Van Holde
Dec 1, 1976·Nucleic Acids Research·A L OlinsD E Olins
Oct 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·H Weintraub, F Van Lente
Nov 1, 1970·Immunochemistry·S Sonoda, M Schlamowitz
Jan 1, 1981·Springer Seminars in Immunopathology·K HannestadA Husebekk
Jan 1, 1980·Annual Review of Biochemistry·J D McGhee, G Felsenfeld
Nov 1, 1959·The Journal of Clinical Investigation·H HOLMAN, H R DEICHER
Jun 1, 1950·The American Journal of the Medical Sciences·J R HASERICKD W BORTZ

❮ Previous
Next ❯

Citations

Aug 15, 1998·Arthritis and Rheumatism·G SchettJ S Smolen
Jan 1, 2000·Arthritis and Rheumatism·J H GilliesJ K Vallance
Jan 1, 1981·Springer Seminars in Immunopathology·K HannestadA Husebekk
Jul 10, 2003·Autoimmunity Reviews·Rufus W Burlingame, Ricard Cervera
Jul 1, 1994·The Journal of Clinical Investigation·R W BurlingameR L Rubin
Apr 1, 1995·Immunological Reviews·D M Klinman, A D Steinberg
Jan 1, 1985·Scandinavian Journal of Rheumatology. Supplement·B D Stollar
Dec 24, 1998·Lupus·C A von MühlenM J Fritzler
Jul 15, 2005·Annals of the New York Academy of Sciences·Danilo VillaltaAndrea Doria
Oct 1, 1991·Clinical and Experimental Immunology·C AtanassovS Muller
Mar 1, 1985·Biochimica Et Biophysica Acta·S MullerM H van Regenmortel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.